Jim Cramer: Allergan Is a Favorite Stock, Teva Deal Was 'Incredible'
Aug 01, 2015 | 9:00 AM EDT - 
Jim Cramer, portfolio manager of Action Alerts PLUS, and research director Jack Mohr sat down to talk about their 'favorite company in the portfolio:' Allergan.

Columnist Conversations

I will stick with my comments on the subject of your post on Bill Gross. Good luck trading today!
Thanks for your extended response. Note, I started my comment out by praising Bill Gross. And while we can c...
There are many (negative) inferences in your post - I wont address all of them. I am surprised you look back a...
While the legend of Bill Gross the trader/investor is nearly unmatched, Bill Gross the predictor leaves quite ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.